These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 20061621

  • 1. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N, Tanaka K.
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [Abstract] [Full Text] [Related]

  • 2. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA, Pickart CM.
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [Abstract] [Full Text] [Related]

  • 3. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.
    Pan T, Kondo S, Le W, Jankovic J.
    Brain; 2008 Aug; 131(Pt 8):1969-78. PubMed ID: 18187492
    [Abstract] [Full Text] [Related]

  • 4. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
    Hol EM, van Leeuwen FW, Fischer DF.
    Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
    Lim KL.
    Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ, Kholod N, van Leeuwen FW.
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G, Schlüter OM, Südhof TC.
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [Abstract] [Full Text] [Related]

  • 13. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM, Fischer DF, Ovaa H, Scheper W.
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
    Hatano T, Kubo S, Sato S, Hattori N.
    J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
    [Abstract] [Full Text] [Related]

  • 16. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F, Kanthasamy A, Anantharam V, Kanthasamy AG.
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, Youdim MB.
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.